tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market
KZIA
Kazia Therapeutics
RESEARCH TOOLSreports
Want to see KZIA full AI Analyst Report?

Kazia Therapeutics (KZIA) Income Statement

329 Followers

Kazia Therapeutics Income Statement

Last quarter (Q2 2026), Kazia Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q2, Kazia Therapeutics's net income was AU$-12.32M. See Kazia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 42.00KAU$ 2.31MAU$ 555.00AU$ 10.00KAU$ 15.18M
Gross Profit
AU$ 42.00KAU$ 2.31MAU$ 555.00AU$ 10.00KAU$ 15.18M
Operating Expenses
AU$ 14.26MAU$ 30.77MAU$ 24.12MAU$ 25.41MAU$ 21.56M
Depreciation and Amortization
AU$ 934.00KAU$ 1.87MAU$ 1.87MAU$ 1.87MAU$ 1.26M
EBITDA
AU$ -13.28MAU$ -26.59MAU$ -22.28MAU$ -23.52MAU$ -5.11M
Operating Income
AU$ -14.22MAU$ -28.46MAU$ -24.12MAU$ -25.40MAU$ -6.38M
Other Income/Expenses
AU$ -8.23MAU$ 1.41MAU$ 3.41MAU$ 17.00KAU$ -2.53M
Pretax Income
AU$ -22.45MAU$ -27.05MAU$ -20.74MAU$ -25.38MAU$ -8.90M
Net Income
AU$ -20.70MAU$ -26.78MAU$ -20.47MAU$ -25.01MAU$ -8.42M
Per Share Metrics
Basic EPS
AU$ -18.90AU$ -55.00AU$ -55.00AU$ -95.00AU$ -35.80
Diluted EPS
AU$ -18.90AU$ -55.00AU$ -55.00AU$ -95.00AU$ -35.80
Weighted Average Shares Outstanding
 1.10M 479.60K 368.60K 265.00K 235.40K
Weighted Average Shares Outstanding (Diluted)
 1.10M 479.60K 368.60K 265.00K 235.40K
Currency in AUD

Kazia Therapeutics Earnings and Revenue History